Amref and AstraZeneca launch mobile clinics to support last mile COVID-19 vaccination efforts in Kenya

AstraZeneca

Amref Health Africa and AstraZeneca (www.AstraZeneca.com), in collaboration with the Ministry of Health (MoH) in Kenya, are launching a fleet of Mobile Vaccination Clinics (MVCs) in an effort to protect last-mile communities from the pandemic. The ten movable clinics will bring COVID-19 vaccines and other health services to hard-to-reach communities across Kenya.

The initiative will help increase vaccine access and uptake in Kenya. As of 17 June 2022, 31.4% of the adult population in Kenya is fully vaccinated against COVID-19[1], while Africa’s average vaccination rate is 17.7% lagging behind other world regions[2].  Each mobile clinic aims to vaccinate 70-100 people per day reaching up to 1,000 people per day once all 10 mobile clinics are fully operational. 

The mobile clinics will help to bridge the COVID-19 vaccine gap by providing vaccine education, COVID-19 screening, safe and accessible vaccination, and post-immunisation care. Operated in partnership with the County Health Departments, and adhering to health and infection prevention control standards, the custom-built clinics are fitted with solar-powered fridges and backup power supply. Timely data capture and reporting is facilitated through onsite web-enabled computers. Amref Flying Doctors (AFD) will replenish the mobile clinics in hard-to-reach areas to ensure their effective deployment.

Dr. Githinji Gitahi, Group CEO Amref Health Africa, said: “It is evident that health emergencies are here to stay, and thinking out of the box through innovations in health may be our only chance at timely response if, and when emergencies occur. Addressing other health determinants such as non-communicable diseases that influence how health emergencies affect us is critical to avert the negative impact that health emergencies such as COVID-19 have on communities.  The movable clinics are, therefore, a great addition to the toolkit that will ensure equity in access to last-mile communities with much-needed vaccination and essential health services. Together with our partners, the Ministry of Health in Kenya, AstraZeneca, and other stakeholders in the private and public sectors, we remain committed to sustaining the momentum towards vaccinating 70% of the eligible population through this innovative solution. Ultimately, the clinics will add to the health system infrastructure, further improving our preparedness for health emergencies in the country.”

Dr Pelin Incesu, Area Vice President, AstraZeneca for the Middle East and Africa said, “We are thrilled to launch this innovative partnership with the Ministry of Health and Amref Health Africa to ensure that no Kenyan is left behind in our efforts to protect lives from COVID-19 and other life-threatening diseases.  This is part of AstraZeneca’s ongoing commitment to a patient-centric response to the pandemic. To date, over three billion doses of our COVID-19 vaccine have been delivered across the globe, helping to save an estimated 3.6 million lives.”

As Kenya integrates vaccination services into primary health care, the clinics will integrate health promotion to raise awareness of non-communicable diseases (NCDs) and provide NCD health service continuity, specifically targeting people living with diabetes and hypertension. When not conducting community outreach, the clinics will support existing public health infrastructure by serving as fixed clinics, thereby reducing the burden on local health facilities.

 


[1] Source: Ministry of Health Kenya. COVID-19 vaccination status: https://bit.ly/3OMIcoR. Last accessed on 25 June 2022

[2] Source: CDC Africa. Africa COVID-19 vaccination dashboard. https://bit.ly/3xZq2cT. Last accessed on 25 June 2022

Distributed by APO Group on behalf of AstraZeneca.

Media Contacts:
Elizabeth (Lizz) Ntonjira
Global Communication Director
Amref Health Africa
+254 719 369 730
[email protected]

AstraZeneca contact person:
[email protected]

About Amref Health Africa (https://Amref.org/home/):
Amref Health Africa, headquartered in Kenya, is the largest Africa-based International Non-Governmental Organisation (INGO). With a focus on increasing sustainable health access, Amref runs programmes in over 35 countries in Africa, with lessons learnt over 60 years of engagement with governments, communities and partners. Amref Health Africa also engages in programme development, fundraising, partnership, advocacy, monitoring and evaluation, and has offices in Europe and North America as well as subsidiaries: Amref Flying Doctors (https://FlyDoc.org/), Amref Enterprises (https://Amref.org/Enterprises/) and the Amref International University (https://Amref.ac.ke/).

About AstraZeneca (https://www.Astrazeneca.com/):
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.Astrazeneca.com  and follow the Company on Twitter https://bit.ly/39WJIWN

Media files
AstraZeneca
Download logo

This Press Release has been issued by APO. The content is not monitored by the editorial team of African Business and not of the content has been checked or validated by our editorial teams, proof readers or fact checkers. The issuer is solely responsible for the content of this announcement.